Pricing

Log inSign up

Facile Therapeutics

0 followers
‌

Facile Therapeutics is bringing Ebselen into the clinic to demonstrate it will be effective in preventing the recurrence of CDI in a Proof-of-Concept (PoC) clinical trial.

Industries

Biotechnology

Headquarters

Belmont, United States

Employees

1-10

Links

Org chart

Marc Navre
Co-Founder, CEO & CSO
Collapse
Allan Wagman
VP of CMC, Consulting Position

Board & advisors

Matthew Bogyo
Co-Founder, Head of Scientific Advisory Board
Ciaran P. Kelly
Chair, Clinical Advisory Board
Peter Tam
Director
Sahil Khanna
Advisor
Ian Friedland
Strategic Medical Advisor
Christine Murray
Strategic Regulatory Advisor
Dan Lundberg
Commercial Advisor
Andrew Parratt
Commercial Strategy Advisor
Andrew McCandlish
Non-Dilutive Funding Advisor

Offices

Similar companies

Gilead Sciences

177 followers

Regeneron

144 followers

Illumina

82 followers

Agilent Technologies

90 followers

Verily Life Sciences

48 followers

Alexion Pharmaceuticals

50 followers

GRAIL

32 followers

Cytiva

20 followers

PerkinElmer

13 followers

Editas Medicine

5 followers

Organogenesis

5 followers

Explore companies